ABC | Volume 112, Nº5, May 2019

Updated Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology – 2019 Arq Bras Cardiol. 2019; 112(5):649-705 10. Demougeot L, van Kan GA, Vellas B, de Souto Barreto P. Frailty detection with the Gérontopôle Frailty Screening Tool (GFST). J Frailty Aging. 2013;2(3):150-2. 11. Abellan van Kan G, Rolland YM, Morley JE, Vellas B. Frailty: toward a clinical definition. J AmMed Dir Assoc. 2008;9(2):71-2. 12. Steverink N, Slaets JPJ, Schuurmans H, van Lis M. Measuring frailty. development and testing of the Groningen Frailty Indicator (GFI). Gerontologist. 2001;41:236-7. 13. Santiago LM, Luz LL, Mattos IE, Gobbens RJ. Adaptação transcultural do instrumento Tilburg Frailty Indicator (TFI) para a população brasileira. Cad Saúde Pública. 2012;28(9):1795-801. 14. RaîcheM, Hébert R, Dubois MF. PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities. Arch Gerontol Geriatr. 2008;47(1):9-18. 15. Saliba D, Elliott M, Rubenstein LZ, Solomon DH, Young RT, Kamberg CJ et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J AmGeriatr Soc. 2001;49(12):1691-9. 16. Fabrício-Wehbe SC, Cruz IR, Haas VJ, Diniz MA, Dantas RA, Rodrigues RA. Adaptação cultural e validade da Edmonton Frail Scale - EFS em uma amostra de idosos brasileiros. Rev Lat Am Enferm. 2009;17(6):1330-6. 17. Chen MA. Frailty and cardiovascular disease: potential role of gait speed in surgical risk stratification in older adults. J Geriatr Cardiol. 2015;12(1):44-56. 18. Alfredsson J, Stebbins A, Brennan JM, Matsouaka R, Afilalo J, Peterson ED et al. Gait speed predicts 30-day mortality after transcatheter aortic valve replacement: results from the Society of Thoracic Surgeons / American College of Cardiology Transcatheter Valve Therapy Registry. Circulation. 2016;133(14):1351-9. 19. Ramos LR, Toniolo J, Cendoroglo MS, Garcia JT, Najas MS, Perracini M et al. Two-year follow-up study of elderly residents in S. Paulo, Brazil: methodology and preliminary results. Rev Saúde Pública. 1998;32(5):397-407. 20. Smith SM, Soubhi H, Fortin M, Hudon C, O'Dowd T. Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ. 2012 Sep 3;345:e5205. 21. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50-8. 22. Freitas EV, Costa EF, Galera CS. Avaliação geriátrica ampla. In: In: Freitas EV, Py L. Tratado de geriatria e gerontologia. 4. ed. Rio de Janeiro: Guanabara Koogan; 2016. p. 152-66. 23. Wajngarten M. Geriatric cardiology: a subspecialty or a need? Arq Bras Cardiol. 2006;87(3):e 8-9. 24. Lucchetti G, Novaes PH, Lucchetti AL. Polifarmácia e adequação do uso demedicamentos. In: Freitas EV, Py L. Tratado de geriatria e gerontologia. 4. ed. Rio de Janeiro: Guanabara Koogan; 2016. p. 1024-30. 25. Bavishi C, Bangalore S, Messerli FH. Outcomes of intensive blood pressure lowering in older hypertensive patients. J Am Coll Cardiol. 2017;69(5):486-93. 26. Bansilal S, Castellano JM, Garrido E, Wei HG, Freeman A, Spettell C et al. Assessingthe impactofmedicationadherenceon long-termcardiovascular outcomes. J Am Coll Cardiol. 2016;68(8):789-801. 27. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227-46. 28. American Geriatrics Society 2015 Updated Beers Criteria for potentially inappropriate medication use in older adults. [Internet]. [Cited in 2016 Sep 10]. Available from: https://www.guidelinescentral.com/summaries/ American-geriatrics-society-2015. 29. Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidle NJ, Budnitz DS. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014. JAMA. 2016;316(20):2115-25. 30. Betz JK, Katz DF, Peterson PN, Borne RT, Al-Khatib SM, Wang Y et al. Outcomes among older patients receiving implantable cardioverter- defibrillators for secondary prevention: from the NCDR ICD Registry. J Am Coll Cardiol. 2017;69(3):265-74. 31. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650-64. 32. American Diabetes Association. 11. Older adults. Diabetes Care. 2017;40(Suppl 1):S99-104. 33. Turner RC, Holman RR, Cull CA, Stratton IM, Matthews, DR, Frighi V et al.; UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin comparedwith conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet. 1998;353(9131):837-53. 34. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-89. 35. Gerstein HC, Miller ME, Byimgton RP, Goff DC Jr, Bigger JT, Buse JB et al.; Action to control cardiovascular risk in diabetes study group: effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-59. 36. Milleer ME, Bonds DE, Gerstein HC, Seaquist ER, Bergenstal RM, Calles-Escandon J et al.; ACCORD Investigators. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study: BMJ. 2010 Jan 8;340:b5444. 37. Patel A, Mac Mahon S, Chalmers J, Neal B, Billot L, Woodward M et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-72. 38. Duckworth W, Abraira C, Moritz TE, Reda D, Emanuele N, Reaven PD et al; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. NEngl J Med. 2009;360(2):129-39. Erratum in: N Engl J Med. 2009;361(10):1028. 39. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, BraccoOL et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375(9713):481-9. 40. Huang ES, Liu JY, Moffer HH, John PM, Karter AJ. Glycemic control, complications, and death in older diabetic patients: the Diabetes and Aging Study. Diabetes Care. 2011;34(6):1329-36. 41. Sociedade Brasileira de Diabetes. Atualização Brasileira sobre Diabetes. Síndrome metabólica. Rio de Janeiro: Diagraphic; 2005. 42. Little D’A. A review of smoking in the elderly. Geriatrics & Aging. 2002;5(9):11-4. 43. Siegel D, Kuller L, Lazarus NB, BlackD, Feigal D, Hughes Get al. Predictors of cardiovascular events and mortality in the Systolic Hypertension in the Elderly Program Pilot Project. Am J Epidemiol. 1987;126(3):385-99. 44. Kawachi I, Colditz GA, Speltzer FE, Manson JE, Stampfer MJ, Willett WC et al. A prospective study of passive smoking and coronary artery disease. Circulation. 1997;95(10):2374-9. 45. Jajich CL, Ostfeld AM, FreemanDH Jr. Smoking and CHD: mortality in the elderly. JAMA. 1984;252(20):2831-4. 46. World Health Organization (WHO). Tobacco knowledge summaries: tobacco and dementia. Geneva; 2014. 47. Dwyer J. Exposure to environmental tobacco smoke and coronary risk. Circulation. 1997;96(5):1367-9. 695